These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14607952)

  • 1. The role of the 19-kDa region of merozoite surface protein 1 and whole-parasite-specific maternal antibodies in directing neonatal pups' responses to rodent malaria infection.
    Stanisic DI; Martin LB; Good MF
    J Immunol; 2003 Nov; 171(10):5461-9. PubMed ID: 14607952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of 19-kDa C-terminal region of merozoite surface protein-1-specific antibody responses in neonatal pups by maternally derived 19-kDa C-terminal region of merozoite surface protein-1-specific antibodies but not whole parasite-specific antibodies.
    Stanisic DI; Martin LB; Gatton ML; Good MF
    J Immunol; 2004 May; 172(9):5570-81. PubMed ID: 15100300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malaria.
    Wipasa J; Hirunpetcharat C; Mahakunkijcharoen Y; Xu H; Elliott S; Good MF
    J Immunol; 2002 Jul; 169(2):944-51. PubMed ID: 12097400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1.
    Hirunpetcharat C; Vukovic P; Liu XQ; Kaslow DC; Miller LH; Good MF
    J Immunol; 1999 Jun; 162(12):7309-14. PubMed ID: 10358180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Mycobacterium bovis bacillus Calmette-GuĂ©rin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.
    Matsumoto S; Yukitake H; Kanbara H; Yamada T
    J Exp Med; 1998 Sep; 188(5):845-54. PubMed ID: 9730886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of immunological nonresponsiveness to the 19-kilodalton fragment of merozoite surface Protein 1 of Plasmodium yoelii: rescue by chemical conjugation to diphtheria toxoid (DT) and enhancement of immunogenicity by prior DT vaccination.
    Stanisic DI; Martin LB; Liu XQ; Jackson D; Cooper J; Good MF
    Infect Immun; 2003 Oct; 71(10):5700-13. PubMed ID: 14500491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
    Jeamwattanalert P; Mahakunkijcharoen Y; Kittigul L; Mahannop P; Pichyangkul S; Hirunpetcharat C
    Clin Vaccine Immunol; 2007 Apr; 14(4):342-7. PubMed ID: 17314232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)).
    Adame-Gallegos JR; Shi J; McIntosh RS; Pleass RJ
    Exp Parasitol; 2012 Apr; 130(4):384-93. PubMed ID: 22343045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa region.
    Ahlborg N; Ling IT; Howard W; Holder AA; Riley EM
    Infect Immun; 2002 Feb; 70(2):820-5. PubMed ID: 11796616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-chain antibodies produced by phage display against the C-terminal 19 kDa region of merozoite surface protein-1 of Plasmodium yoelii reduce parasite growth following challenge.
    Vukovic P; Chen K; Qin Liu X; Foley M; Boyd A; Kaslow D; Good MF
    Vaccine; 2002 Jun; 20(21-22):2826-35. PubMed ID: 12034110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyspecific malaria antibodies present at the time of infection inhibit the development of immunity to malaria but antibodies specific for the malaria merozoite surface protein, MSP1, facilitate immunity.
    Zhang W; Liu XQ; Xu H; Good MF
    Parasite Immunol; 2002 May; 24(5):233-41. PubMed ID: 12060317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
    J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene gun-based co-immunization of merozoite surface protein-1 cDNA with IL-12 expression plasmid confers protection against lethal Plasmodium yoelii in A/J mice.
    Sakai T; Hisaeda H; Nakano Y; Zhang M; Takashima M; Ishii K; Maekawa Y; Matsumoto S; Nitta Y; Miyazaki Ji; Yamamoto S; Himeno K
    Vaccine; 2003 Mar; 21(13-14):1432-44. PubMed ID: 12615440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
    Rotman HL; Daly TM; Clynes R; Long CA
    J Immunol; 1998 Aug; 161(4):1908-12. PubMed ID: 9712060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains.
    Somner EA; Ogun SA; Sinha KA; Spencer Valero LM; Lee JJ; Harrison JA; Holder AA; Hormaeche CE; Khan ACM
    Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():221-229. PubMed ID: 10206702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite.
    Kang Y; Calvo PA; Daly TM; Long CA
    J Immunol; 1998 Oct; 161(8):4211-9. PubMed ID: 9780195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).
    Ahlborg N; Ling IT; Holder AA; Riley EM
    Infect Immun; 2000 Apr; 68(4):2102-9. PubMed ID: 10722607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria.
    Daly TM; Long CA
    J Immunol; 1995 Jul; 155(1):236-43. PubMed ID: 7602100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection.
    Petritus PM; Burns JM
    J Immunol; 2008 Jan; 180(1):444-53. PubMed ID: 18097046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Plasmodium yoelii exposure on vaccination with the 19-kilodalton carboxyl terminus of merozoite surface protein 1 and vice versa and implications for the application of a human malaria vaccine.
    Wipasa J; Xu H; Liu X; Hirunpetcharat C; Stowers A; Good MF
    Infect Immun; 2009 Feb; 77(2):817-24. PubMed ID: 19015251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.